Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade

DIABETES

AMER DIABETES ASSOC

1. Merck & Co., Inc., Rahway, NJ